6 Patents
- US124199532025Methods of Treatment or Prevention of Immune Responses and Inflammatory Diseases with Antagonistic CD40 Monoclonal Antibodies
Bristol-myers Squibb Company
0 cites - 0 cites
- 0 cites
- 0 cites
- 0 cites
- US116239652023Prodruggable Antibodies, Prodrugs Thereof, and Methods of Use and Making
Bristol-myers Squibb Company
0 cites